453 related articles for article (PubMed ID: 27661006)
1. Type I insulin-like growth factor receptor signaling in hematological malignancies.
Vishwamitra D; George SK; Shi P; Kaseb AO; Amin HM
Oncotarget; 2017 Jan; 8(1):1814-1844. PubMed ID: 27661006
[TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.
Bieghs L; Johnsen HE; Maes K; Menu E; Van Valckenborgh E; Overgaard MT; Nyegaard M; Conover CA; Vanderkerken K; De Bruyne E
Oncotarget; 2016 Jul; 7(30):48732-48752. PubMed ID: 27129151
[TBL] [Abstract][Full Text] [Related]
3. Disrupting insulin-like growth factor signaling as a potential cancer therapy.
Sachdev D; Yee D
Mol Cancer Ther; 2007 Jan; 6(1):1-12. PubMed ID: 17237261
[TBL] [Abstract][Full Text] [Related]
4. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer.
Philippou A; Christopoulos PF; Koutsilieris DM
Mutat Res Rev Mutat Res; 2017; 772():105-122. PubMed ID: 28528684
[TBL] [Abstract][Full Text] [Related]
6. [Advancement of insulin effecting signaling pathway of leukemia cell proliferation].
Huang YQ; Pan JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):514-7. PubMed ID: 22541130
[TBL] [Abstract][Full Text] [Related]
7. Low Oxygen Tension Modulates the Insulin-Like Growth Factor-1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem Cells.
Youssef A; Han VK
Endocrinology; 2016 Mar; 157(3):1163-74. PubMed ID: 26760116
[TBL] [Abstract][Full Text] [Related]
8. A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line.
Benabbou N; Mirshahi P; Bordu C; Faussat AM; Tang R; Therwath A; Soria J; Marie JP; Mirshahi M
Int J Oncol; 2014 Oct; 45(4):1372-80. PubMed ID: 25095896
[TBL] [Abstract][Full Text] [Related]
9. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
Camidge DR; Dziadziuszko R; Hirsch FR
Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
[TBL] [Abstract][Full Text] [Related]
10. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins.
Goel HL; Fornaro M; Moro L; Teider N; Rhim JS; King M; Languino LR
J Cell Biol; 2004 Aug; 166(3):407-18. PubMed ID: 15289498
[TBL] [Abstract][Full Text] [Related]
11. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
12. The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.
Guvakova MA; Lee WS; Furstenau DK; Prabakaran I; Li DC; Hung R; Kushnir N
Biochem J; 2014 Oct; 463(2):257-70. PubMed ID: 25028810
[TBL] [Abstract][Full Text] [Related]
13. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
Doepfner KT; Spertini O; Arcaro A
Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
[TBL] [Abstract][Full Text] [Related]
14. Anti-insulin-like growth factor strategies in breast cancer.
Jerome L; Shiry L; Leyland-Jones B
Semin Oncol; 2004 Feb; 31(1 Suppl 3):54-63. PubMed ID: 15052543
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
Ohashi H; Adachi Y; Yamamoto H; Taniguchi H; Nosho K; Suzuki H; Arimura Y; Imai K; Carbone DP; Shinomura Y
Cancer Sci; 2012 Feb; 103(2):252-61. PubMed ID: 22044563
[TBL] [Abstract][Full Text] [Related]
16. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
Malaguarnera R; Nicolosi ML; Sacco A; Morcavallo A; Vella V; Voci C; Spatuzza M; Xu SQ; Iozzo RV; Vigneri R; Morrione A; Belfiore A
Oncotarget; 2015 Jun; 6(18):16084-105. PubMed ID: 25840417
[TBL] [Abstract][Full Text] [Related]
17. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts.
Yoshimoto H; Ishihara H; Ohtsuru A; Akino K; Murakami R; Kuroda H; Namba H; Ito M; Fujii T; Yamashita S
Am J Pathol; 1999 Mar; 154(3):883-9. PubMed ID: 10079266
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis.
Werner H; Le Roith D
Crit Rev Oncog; 1997; 8(1):71-92. PubMed ID: 9516087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
